Entry Detail



General Information

Database ID:exR0000023
RNA Name:AATF
RNA Type:mRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):36948954End Site(bp):37056871
External Links:ENSG00000275700



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
SSR1
chr6
7268306
7347446
-
RPS19
chr19
41860255
41872925
+
THY1
chr11
119417378
119424985
-
EIF3B
chr7
2354086
2380745
+
CD74
chr5
150400041
150412929
-
CASP2
chr7
143288215
143307696
+
BDH1
chr3
197509783
197573323
-
RNF113A
chrX
119870475
119871733
-
RTCA
chr1
100266207
100292769
+
AP002990.1
chr11
62559603
62591531
-
CKB
chr14
103519667
103522833
-
CLDN23
chr8
8701937
8704096
+
RPL8
chr8
144789765
144792587
-
VLDLR
chr9
2621787
2660056
+
ACTB
chr7
5527148
5563784
-
MT-CO3
chrMT
9207
9990
+
RPS6
chr9
19375715
19380236
-
NIPA2
chr15
22838641
22868384
+
UBA52
chr19
18571730
18577550
+
DYNC1H1
chr14
101964573
102056443
+
UBALD2
chr17
76265348
76271298
+
LSM1
chr8
38163335
38176730
-
CIC
chr19
42268537
42295797
+
PAQR3
chr4
78887127
78939438
-
CCNA2
chr4
121816444
121823933
-
TMEM258
chr11
61768501
61792802
-
ACTR1B
chr2
97655939
97664044
-
CIT
chr12
119685791
119877320
-
FAN1
chr15
30890559
30943108
+
SRGN
chr10
69088103
69104805
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-4492
chr11
118910765
118910781
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL355987.4
chr9
136799223
136810042
+
NAALADL2-AS2
chr3
175234861
175271096
-
SNHG1
chr11
62851984
62855953
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.